Sumitomo Mitsui Trust Group Inc. Has $10.32 Million Stock Holdings in American Healthcare REIT, Inc. $AHR

Sumitomo Mitsui Trust Group Inc. lowered its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 9.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 245,732 shares of the company’s stock after selling 27,131 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.15% of American Healthcare REIT worth $10,323,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AHR. Creative Planning raised its stake in shares of American Healthcare REIT by 4.5% during the second quarter. Creative Planning now owns 37,467 shares of the company’s stock worth $1,377,000 after buying an additional 1,628 shares during the last quarter. Envestnet Portfolio Solutions Inc. acquired a new stake in American Healthcare REIT during the 2nd quarter worth approximately $207,000. First American Bank bought a new position in American Healthcare REIT in the third quarter valued at approximately $1,681,000. Franklin Resources Inc. increased its position in shares of American Healthcare REIT by 44.3% during the second quarter. Franklin Resources Inc. now owns 236,110 shares of the company’s stock worth $8,675,000 after acquiring an additional 72,502 shares in the last quarter. Finally, Orion Porfolio Solutions LLC increased its position in shares of American Healthcare REIT by 101.3% during the second quarter. Orion Porfolio Solutions LLC now owns 30,057 shares of the company’s stock worth $1,104,000 after acquiring an additional 15,128 shares in the last quarter. 16.68% of the stock is currently owned by institutional investors and hedge funds.

American Healthcare REIT Stock Up 0.2%

NYSE:AHR opened at $48.06 on Friday. American Healthcare REIT, Inc. has a twelve month low of $26.48 and a twelve month high of $51.01. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 343.29, a price-to-earnings-growth ratio of 1.82 and a beta of 1.02. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.37. The stock’s 50 day moving average price is $48.41 and its two-hundred day moving average price is $43.72.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 16th. Shareholders of record on Wednesday, December 31st were given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, December 31st. American Healthcare REIT’s dividend payout ratio is 714.29%.

Insiders Place Their Bets

In other news, EVP Mark E. Foster sold 1,500 shares of American Healthcare REIT stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total value of $74,025.00. Following the completion of the transaction, the executive vice president owned 57,600 shares of the company’s stock, valued at $2,842,560. This trade represents a 2.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jeffrey T. Hanson sold 19,208 shares of the business’s stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price of $48.40, for a total transaction of $929,667.20. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 76,288 shares of company stock valued at $3,718,666. Corporate insiders own 0.92% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on AHR shares. UBS Group upped their target price on shares of American Healthcare REIT from $51.00 to $56.00 and gave the stock a “buy” rating in a research note on Monday, November 17th. Citizens Jmp upped their price objective on American Healthcare REIT from $50.00 to $60.00 and gave the stock a “market outperform” rating in a research report on Monday, November 10th. Morgan Stanley increased their price objective on American Healthcare REIT from $52.00 to $55.00 and gave the stock an “overweight” rating in a report on Thursday, November 20th. Zacks Research cut American Healthcare REIT from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 1st. Finally, JMP Securities raised their price target on shares of American Healthcare REIT from $45.00 to $50.00 and gave the stock a “market outperform” rating in a research note on Friday, October 17th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $51.64.

American Healthcare REIT Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.